Title : A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations.

Pub. Date : 2011 Aug

PMID : 21847063






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations. farnesylthiosalicylic acid KRAS proto-oncogene, GTPase Homo sapiens
2 This phase II study determined the activity of salirasib in patients with advanced lung adenocarcinomas with KRAS mutations. farnesylthiosalicylic acid KRAS proto-oncogene, GTPase Homo sapiens